Financial

Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update

MONTREAL and CHARLOTTE, N.C., Aug. 12, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the second quarter ended June 30, 2020 and provided a clinical and corporate update. “With the benefit of having completed our first Phase 3 clinical trial and […]

Bellerophon Appoints Cardiopulmonary Disease Expert Wassim Fares, M.D., MSCR, as Chief Medical Officer

WARREN, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, announced today that it has appointed Wassim Fares, M.D., MSCR, as Chief Medical Officer. “We are thrilled to welcome Wassim, […]

Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CARLSBAD, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB),  today announced the closing of its initial public offering of 10,147,058 shares of common stock, which includes the exercise in full of the underwriters’ option to purchase 1,323,529 additional shares of its common stock, at a […]

Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update

– Highest Quarterly and First Half Total Revenue in Company History with $214 million in Total YTD Revenue – – Strong Capital Position with over $300 Million in Cash – – Extraordinary High-Quality Managed Care Coverage with Over 80% Commercial and Over 50% Medicare Part D Formulary Coverage – – Consistently High Month-Over-Month […]

Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights

– ENHANCE-IT study of MAT9001 against Vascepa® expected to be fully enrolled in August 2020; topline data anticipated Q1 2021 – – EnACT study of MAT2203 in cryptococcal meningitis resumed enrollment; on track for potential cohort progression Q4 2020 – – Management to host conference call today, Monday, August 10th, at […]

Katherine B. Quinn, Vice Chair and Chief Administrative Officer of U.S. Bancorp, joins Ontrak Board of Directors

SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced the appointment of Katherine B. Quinn, Vice Chairman and Chief Administrative Officer of US Bancorp, a 70,000 employee and $547 Billion enterprise, to its Board of Directors. Mr. […]

Bodyport Raises $11.2 Million in Series A Funding to Launch Virtual Cardiac Clinic

Investments from Boehringer Ingelheim Venture Fund (BIVF), Playground Global and Initialized Capital will advance the prevention and management of heart disease SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced the close of an $11.2 million Series A investment round. Boehringer […]

Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offerings

Automated Imaging Analysis Technology Can Help Clinicians Provide Faster, Accurate Diagnoses; Integration Marks the Introduction of Zebra-Med’s Solution into the Modality Space TUSTIN, Calif.–(BUSINESS WIRE)–Building on its commitment to providing customers with Artificial Intelligence (AI) solutions that can be utilized across modalities in routine care, Canon Medical Systems USA, Inc. is partnering […]